Viemed Healthcare, Inc.
VMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $311 | $301 | $292 | $206 |
| - Cash | $18 | $13 | $17 | $28 |
| + Debt | $7 | $10 | $1 | $7 |
| Enterprise Value | $300 | $299 | $276 | $184 |
| Revenue | $224 | $183 | $139 | $117 |
| % Growth | 22.5% | 31.8% | 18.6% | – |
| Gross Profit | $133 | $113 | $85 | $73 |
| % Margin | 59.4% | 61.6% | 61% | 62.7% |
| EBITDA | $42 | $37 | $25 | $24 |
| % Margin | 18.9% | 20% | 17.9% | 20.6% |
| Net Income | $11 | $10 | $6 | $9 |
| % Margin | 5% | 5.6% | 4.5% | 7.8% |
| EPS Diluted | 0.28 | 0.25 | 0.15 | 0.22 |
| % Growth | 12% | 66.7% | -31.8% | – |
| Operating Cash Flow | $39 | $45 | $28 | $22 |
| Capital Expenditures | -$38 | -$26 | -$23 | -$20 |
| Free Cash Flow | $1 | $19 | $5 | $3 |